IBR2 is a potent and specific RAD51 inhibitor and inhibits RAD51 -mediated DNA double-strand break repair. IBR2 disrupts RAD51 multimerization, accelerates proteasome-mediated RAD51 protein degradation, inhibits cancer cell growth and induces apoptosisIn VitroIBR2 shows interesting RAD51 inhibition activities. RAD51 is rapidly degraded in IBR2-treated cancer cells, and the homologous recombination repair is impaired, subsequently leading to cell death. The IC 50 values of the original IBR2 are in the range of 12-20 μM for most tested cancer cell lines. IBR2 can inhibit the growth of triple-negative human breast cancer cell line MBA-MD-468 with an IC 50 of 14.8 μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:RAD51.
Specifications and Purity: ≥98%
Molecular Formula: C24H20N2O2S
Molecular Weight: 400.5
PubChem CID: 4664423
Isomeric SMILES: C1=CC=C(C=C1)CS(=O)(=O)N2C=CC3=CC=CC=C3C2C4=CNC5=CC=CC=C54
- UPC:
- 41113318
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- I646314-100mg
- CAS:
- 313526-24-8
- Product Size:
- 100mg
akash.verma@cenmed.com
(732) 447-1115





